Abstract
Cryoproteins are blood protein that can be precipitated by cooling and redissolved by warming. We distinguish cryoglobulins that precipitate in serum’s patient and cryofibrinogenemia that precipitate in plasma with cold (Table 9.1). The prevalence of cryoglobulinemia vasculitis has been reported as approximately 10 per million inhabitants [1]. However, the prevalence and incidence of cryoglobulinemia vasculitis is difficult to estimate because of the numerous cause and clinical presentation. Cryofibrinogenemia represents 10% of cryoproteins. Essential cryofibrinogenemia is rare but its prevalence remains unknown. A study in 36,000 hospitalized patients reported a prevalence of 3.4% of cryofibrinogenemia [2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med. 1980;69(2):287–308.
Smith SB, Arkin C. Cryofibrinogenemia: incidence, clinical correlations, and a review of the literature. Am J Clin Pathol. 1972;58(5):524–30.
Saadoun D, Elalamy I, Ghillani-Dalbin P, Sene D, Delluc A, Cacoub P. Cryofibrinogenemia: new insights into clinical and pathogenic features. Am J Med. 2009;122(12):1128–35.
Korst DR, Kratochvil CH. Cryofibrinogen in a case of lung neoplasm associated with thrombophlebitis migrans. Blood. 1955;10(9):945–53.
Stathakis NE, Karamanolis D, Koukoulis G, Tsianos E. Characterization of cryofibrinogen isolated from patients plasma. Haemostasis. 1981;10(4):195–202.
Amdo TD, Welker JA. An approach to the diagnosis and treatment of cryofibrinogenemia. Am J Med. 2004;116(5):332–7.
Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med. 1974;57(5):775–88.
Blain H, Cacoub P, Musset L, Costedoat-Chalumeau N, Silberstein C, Chosidow O, et al. Cryofibrinogenaemia: a study of 49 patients. Clin Exp Immunol. 2000;120(2):253–60.
Kalbfleisch JM, Bird RM. Cryofibrinogenemia. N Engl J Med. 1960;263:881–6.
Belizna CC, Tron F, Joly P, Godin M, Hamidou M, Lévesque H. Outcome of essential cryofibrinogenaemia in a series of 61 patients. Rheumatology (Oxford). 2008;47(2):205–7.
Rachmilewitz EA, Sacks MI, Zlotnick A. Essential cryofibrinogenemia. Clinical, pathological and immunological studies. Isr J Med Sci. 1970;6(1):32–43.
Euler HH, Zeuner RA, Béress R, Gutschmidt HJ, Christophers E, Schroeder JO. Monoclonal cryo-antifibrinogenemia. Arthritis Rheum. 1996;39(6):1066–9.
Copeman PW. Cryofibrinogenaemia and skin ulcers: treatment with plasmapheresis. Br J Dermatol. 1979;101(Suppl 17):57–8.
Terrier B, Krastinova E, Marie I, Launay D, Lacraz A, Belenotti P, et al. Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey. Blood. 2012;119(25):5996–6004.
Terrier B, Karras A, Kahn J-E, Le Guenno G, Marie I, Benarous L, et al. The Spectrum of type I Cryoglobulinemia vasculitis: new insights based on 64 cases. Medicine. 2013;92(2):61–8.
Fermand J-P, Bridoux F, Kyle RA, Kastritis E, Weiss BM, Cook MA, et al. How I treat monoclonal gammopathy of renal significance (MGRS). Blood. 2013;122(22):3583–90.
Harel S, Mohr M, Jahn I, Aucouturier F, Galicier L, Asli B, et al. Clinico-biological characteristics and treatment of type I monoclonal cryoglobulinaemia: a study of 64 cases. Br J Haematol. 2015;168(5):671–8.
Sidana S, Rajkumar SV, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, et al. Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia. Am J Hematol. 2017;92(7):668–73.
Cacoub P, Desbois AC, Comarmond C, Saadoun D. Impact of sustained virological response on the extrahepatic manifestations of chronic hepatitis C: a meta-analysis. Gut. 2018;67(11):2025–34.
Cacoub P, Vautier M, Desbois AC, Lafuma A, Saadoun D. Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: from interferon-based to direct-acting antivirals era. Liver Int. 2017;37(12):1805–13.
Cacoub P, Delluc A, Saadoun D, Landau DA, Sene D. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand? Ann Rheum Dis. 2008;67(3):283–7.
Saadoun D, Resche Rigon M, Sene D, Terrier B, Karras A, Perard L, et al. Rituximab plus peg-interferon-alpha/ribavirin compared with peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia. Blood. 2010;116(3):326–34; quiz 504–5.
Terrier B, Marie I, Launay D, Lacraz A, Belenotti P, de Saint-Martin L, et al. Predictors of early relapse in patients with non-infectious mixed cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey. Autoimmun Rev. 2014;13(6):630–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Vautier, M., Saadoun, D. (2023). Unusual Ulcers of the Extremities: Cryofibrinogenemia and Cryoglobulinemia. In: Khanna, A.K., Tiwary, S.K. (eds) Uncommon Ulcers of the Extremities. Springer, Singapore. https://doi.org/10.1007/978-981-99-1782-2_9
Download citation
DOI: https://doi.org/10.1007/978-981-99-1782-2_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-1781-5
Online ISBN: 978-981-99-1782-2
eBook Packages: MedicineMedicine (R0)